tacalyx raised €11M in a Seed round announced on April 30, 2026. Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA.
Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA.
tacalyx, based in Berlin, Germany, announced €11M in Seed financing on April 30, 2026.
Participants include Creathor Ventures, Kurma Partners, High-Tech Gründerfonds, Thuja Capital, Eurazeo, Boehringer Ingelheim Venture Fund (BIVF).
Ineffable Intelligence is using Reinforcement Learning to create a “superlearner” that can endlessly discover knowledge and skills without relying on human data.
A biotechnology company developing small molecule drugs that target RNA modifying enzymes for the treatment of cancer.